kabutan

AIN HOLDINGS rebounds on higher prescription prices, FY April 2026 earnings exceed plan

Tue Jun 2, 2026 9:54 am JST Catalyst

Shares of AIN HOLDINGS INC. <9627> rebounded on Tuesday after the company announced that its full-year consolidated earnings for the fiscal year ended April 2026 beat its previous forecasts. Sales reached 647.5 billion yen (up 41.7% year-on-year) against the prior estimate of 646.0 billion yen. Operating profit rose to 29.5 billion yen (up 74.9%) from 28.3 billion yen, while net profit climbed to 17.0 billion yen (up 83.6%) from 13.5 billion yen.

Earnings were driven by higher prescription unit prices from high-value pharmaceuticals and steady volume growth in the core pharmacy business. Smooth post-merger integration (PMI) at Sakura Pharmacy Group, which joined the company on Aug. 1, 2025, also lifted results. Alongside the upward revision, AIN HOLDINGS raised its year-end dividend forecast to 100 yen per share from 80 yen.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles